science

HIF prolyl-hydroxylase inhibitor

HIF prolyl-hydroxylase inhibitor is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand HIF prolyl-hydroxylase inhibitor rather than just read about it. In short: Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are a novel class of oral medications developed for the treatment of anemia in chronic kidney disease (CKD). These drugs work by inhibiting hypoxia-inducible factor-proline dioxygenase (HIF prolyl-hydroxylase), which are responsible for the degradation of hypoxia-inducible factor (HIF) under normal oxygen conditions.

Key takeaways

HIF prolyl-hydroxylase inhibitor belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect HIF prolyl-hydroxylase inhibitor to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of HIF prolyl-hydroxylase inhibitor from memory before moving on to harder problems.

Reference excerpt

Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are a novel class of oral medications developed for the treatment of anemia in chronic kidney disease (CKD). These drugs work by inhibiting hypoxia-inducible factor-proline dioxygenase (HIF prolyl-hydroxylase), which are responsible for the degradation of hypoxia-inducible factor (HIF) under normal oxygen conditions. By stabilizing HIF, these inhibitors mimic the body's natural response to hypoxia, leading to increased endogenous erythropoietin production and improved iron metabolism. HIF-PHIs have shown efficacy in correcting and maintaining hemoglobin levels in both dialysis-dependent and non-dialysis-dependent CKD patients, offering an alternative to traditional erythropoiesis-stimulating agents (ESAs).

Therapeutic applications

Renal anemia Several HIF-PHIs, including roxadustat, daprodustat, vadadustat, molidustat, and enarodustat, have been approved in various countries for the treatment of renal anemia. While these drugs have demonstrated promising results in clinical trials, ongoing research is focused on evaluating their long-term safety profile, particularly regarding cardiovascular outcomes, thromboembolic events, and potential effects on tumor growth.

Other indications Outside of chronic kidney disease, Akebia Therapeutics has reported preliminary findings from its phase II study on Vadadustat for acute respiratory distress syndrome (ARDS) in COVID-19 patients. Based on these results, Akebia Therapeutics plans to proceed with a phase III study targeting a broader ARDS patient population.

Regulatory status In Japan, all three drugs are available for clinical use. In the European Union, Vadadustat and Daprodustat are currently under regulatory review for potential approval as of 2023. In early 2023, the U.S. FDA approved Daprodustat following a positive advisory committee decision, which supported its favorable benefit-risk profile. Vadadustat, however, is awaiting a decision on a formal dispute resolution appeal, especially in light of the recent FDA approval for Daprodustat.

Clinical development As of 2023, Vadadustat, Daprodustat, and Roxadustat are the most extensively studied HIF-PHIs, with a significant volume of phase III and phase IV data supporting their use in treating chronic kidney disease.

Commercial development The rights to Vadadustat are held by Akebia Therapeutics in partnership with CSL Vifor. Roxadustat is owned by Fibrogen in partnership with Astellas, while Daprodustat has been developed internally by GSK.

Examples Daprodustat Desidustat Enarodustat Molidustat Roxadustat (marketed in China) Vadadustat

See also Hypoxia-inducible factors#As a therapeutic target

References

Illustrations

Worked examples

Example 1 — a first encounter with HIF prolyl-hydroxylase inhibitor

Start with the simplest possible case. Write down what HIF prolyl-hydroxylase inhibitor claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to HIF prolyl-hydroxylase inhibitor before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about HIF prolyl-hydroxylase inhibitor ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of HIF prolyl-hydroxylase inhibitor

In research: HIF prolyl-hydroxylase inhibitor appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses HIF prolyl-hydroxylase inhibitor in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: HIF prolyl-hydroxylase inhibitor is common in secondary-school and first-year university syllabi. It links to neighbouring topics Blood and blood forming organ drug stubs, Enzyme inhibitors, so understanding it makes those chapters shorter.
In everyday life: Look for HIF prolyl-hydroxylase inhibitor outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “HIF prolyl-hydroxylase inhibitor” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study HIF prolyl-hydroxylase inhibitor in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what HIF prolyl-hydroxylase inhibitor means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain HIF prolyl-hydroxylase inhibitor out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is HIF prolyl-hydroxylase inhibitor in simple terms?

Why does HIF prolyl-hydroxylase inhibitor matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study HIF prolyl-hydroxylase inhibitor?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on HIF prolyl-hydroxylase inhibitor.